This article is from the source 'guardian' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.theguardian.com/society/2017/aug/07/global-shortage-of-hepatitis-b-vaccine-declared
The article has changed 7 times. There is an RSS feed of changes available.
Version 0 | Version 1 |
---|---|
Global shortage of hepatitis B vaccine declared | Global shortage of hepatitis B vaccine declared |
(35 minutes later) | |
Public Health England has announced a global shortage of the hepatitis B vaccine. | |
Emergency measures have been put in place to protect those at highest immediate risk by the shortage, which has been caused by problems in the manufacturing process. | |
The measures, which mean only those at highest risk will receive the vaccine while others will have to wait, are expected to continue until 2018. | |
Hepatitis B is an infection of the liver, which is spread through contact with infected blood and body fluids. | Hepatitis B is an infection of the liver, which is spread through contact with infected blood and body fluids. |
The risk of catching hepatitis B in the UK is very low, but the vaccine is usually offered to individuals who are at specific risk of being exposed to body fluids from an infected person. | |
This includes babies born to mothers who are infected with hepatitis B, the sexual partners of infected individuals and a range of other groups such as men who have sex with men, healthcare workers and intravenous drug users. It is also recommended for anyone undertaking activities such as getting a tattoo overseas. | |
The recently announced addition of hepatitis B protection to the routine childhood immunisation programme at two, three and four months will go ahead as the combined vaccine is not affected by the shortage. | |
Clare Cook, a spokeswoman for PHE, said: “The manufacturers are getting more stock in but there has been an issue for a while so that’s why we have put this prioritisation guidance into place. We know that the Hepatitis B vaccine takes a long time and is quite difficult to manufacture. | Clare Cook, a spokeswoman for PHE, said: “The manufacturers are getting more stock in but there has been an issue for a while so that’s why we have put this prioritisation guidance into place. We know that the Hepatitis B vaccine takes a long time and is quite difficult to manufacture. |
“We will make sure those who really need the vaccine will get it, and those who are less at risk should get it at a later date. It’s important to note that we are a very low risk country for hepatitis B, and the most at risk group are babies,. | |
“The most common route of transmission is when a baby is born to a mother who has it but the paediatric vaccine is not affected by the shortage.” | “The most common route of transmission is when a baby is born to a mother who has it but the paediatric vaccine is not affected by the shortage.” |
Individuals can reduce their risk of contracting hepatitis B by avoiding unprotected sex and injecting drugs, by not sharing needles when injecting, by avoiding having tattoos, piercings or acupuncture when overseas and by avoiding medical or dental care in high-prevalence countries. | |
Cook said: “We think there will be shortages until early 2018 so we are urging people to make sure they are taking the right precautions while the shortage is ongoing.” | Cook said: “We think there will be shortages until early 2018 so we are urging people to make sure they are taking the right precautions while the shortage is ongoing.” |